A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...

Virion Therapeutics, LLC, a clinical-stage biotechnology company, developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at AASLD's The Liver Meeting (R) , in ...

In a new study published in the biomedical journal Science Translational Medicine on Wednesday, researchers revealed for the ...

ST. LOUIS – Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and resurfacing even after treatment. But, thanks to a new class of ...

From 2014 to 2021, approximately only one-third of US adults diagnosed with hepatitis C received treatment, despite curative therapies.

Researchers have solved the first step in treating the common cold, by mapping its entire genome, or genetic map, teams from the University of Maryland and the University of Wisconsin-Madison reported ...

Ruzasvir has demonstrated highly potent and pan-genotypic antiviral activity in preclinical (picomolar range) and clinical studies. Ruzasvir has been administered to over 2,100 subjects at daily doses ...